	US 12,084,550 B2
	Vehicles and delivery systems for oxidizing agents
Carla Jehan Catherine Spina, Toronto (CA); and Johanny Elizabeth Notarandrea Alfonzo, Toronto (CA)
Assigned to EXCITON PHARMA CORP., (CA)
Appl. No. 17/252,640
Filed by EXCITON PHARMA CORP., Toronto (CA)
PCT Filed Jul. 26, 2018, PCT No. PCT/CA2018/050907 § 371(c)(1), (2) Date Dec. 15, 2020, PCT Pub. No. WO2020/019050, PCT Pub. Date Jan. 30, 2020.
Prior Publication US 2021/0253804 A1, Aug. 19, 2021
Int. Cl. C08J 3/22 (2006.01); C08K 3/22 (2006.01); C08K 3/28 (2006.01); C08K 3/36 (2006.01); B82Y 30/00 (2011.01); B82Y 40/00 (2011.01)

CPC C08J 3/226 (2013.01) [C08K 3/22 (2013.01); C08K 3/28 (2013.01); C08K 3/36 (2013.01); B82Y 30/00 (2013.01); B82Y 40/00 (2013.01); C08J 2383/04 (2013.01); C08K 2003/2241 (2013.01); C08K 2201/011 (2013.01)]

38 Claims

1. A semi-solid composition comprising:

a hydrophobic continuous phase comprising an oxidizing agent comprising a metal in the form of metal (II) or metal (III) oxidation state or a combination thereof, and a non-aqueous solvent; and

a disperse hydrophilic phase comprising nanostructured silica.